Sotera Health Operating Income Over Time
| SHC Stock | USD 15.79 0.09 0.57% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Sotera Health Performance and Sotera Health Correlation. Will Life Sciences Tools & Services sector continue expanding? Could Sotera diversify its offerings? Factors like these will boost the valuation of Sotera Health. If investors know Sotera will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Sotera Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.754 | Earnings Share 0.27 | Revenue Per Share | Quarterly Revenue Growth 0.046 | Return On Assets |
The market value of Sotera Health is measured differently than its book value, which is the value of Sotera that is recorded on the company's balance sheet. Investors also form their own opinion of Sotera Health's value that differs from its market value or its book value, called intrinsic value, which is Sotera Health's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Sotera Health's market value can be influenced by many factors that don't directly affect Sotera Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sotera Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sotera Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Sotera Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Operating Income Analysis
Compare Sotera Health and related stocks such as Protagonist Therapeutics, Oscar Health, and Arcellx Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PTGX | (9.3 M) | (9.3 M) | (9.3 M) | (9.3 M) | (9.3 M) | (14.8 M) | (32.7 M) | (37.9 M) | (42.3 M) | (80.5 M) | (64.5 M) | (125.8 M) | (131.4 M) | (93.7 M) | 252.8 M | (158.1 M) | (150.2 M) |
| OSCR | (259.4 M) | (259.4 M) | (259.4 M) | (259.4 M) | (259.4 M) | (259.4 M) | (259.4 M) | (259.4 M) | (259.4 M) | (259.4 M) | (405.8 M) | (570.6 M) | (610.1 M) | (235.6 M) | 57.3 M | (396.4 M) | (416.2 M) |
| ACLX | (8.3 M) | (8.3 M) | (8.3 M) | (8.3 M) | (8.3 M) | (8.3 M) | (8.3 M) | (8.3 M) | (8.3 M) | (18 M) | (32.1 M) | (65 M) | (191.3 M) | (89.9 M) | (137.6 M) | (253.1 M) | (240.4 M) |
| MMSI | (400 K) | 33.2 M | 29.6 M | 27.8 M | 40.2 M | 37.5 M | 34.9 M | 33.1 M | 58.6 M | 15.4 M | (1.6 M) | 60.9 M | 87.6 M | 123.9 M | 155.7 M | 184.7 M | 194 M |
| OPCH | 33.1 M | 44.9 M | 13.3 M | (26.3 M) | 11.9 M | (287.6 M) | (36.2 M) | (63.3 M) | 38.3 M | (319 K) | 110.8 M | 190.8 M | 240.2 M | 314.6 M | 321.8 M | 337.9 M | 354.8 M |
| GKOS | (22.1 M) | (22.1 M) | (22.1 M) | (14.2 M) | (13.2 M) | (10.3 M) | 4.2 M | (2.3 M) | (13 M) | (50.3 M) | (123.6 M) | (32.9 M) | (82.3 M) | (128.7 M) | (122.4 M) | (199.6 M) | (189.6 M) |
| TMDX | (18.2 M) | (23 M) | (23 M) | (23 M) | (23 M) | (23 M) | (23 M) | (20.4 M) | (20.2 M) | (29.6 M) | (26.4 M) | (39.4 M) | (31.4 M) | (28.7 M) | 37.5 M | 108.6 M | 114 M |
| ALKS | (42.3 M) | 81.8 M | 81.8 M | 15.5 M | (87.1 M) | (224.3 M) | (208.7 M) | (147.9 M) | (99.1 M) | (175.5 M) | (112.4 M) | 97.7 M | (6.1 M) | 414.1 M | 420.6 M | 254 M | 266.7 M |
| TFX | 20.6 M | 233.2 M | (97.4 M) | 233.3 M | 284.9 M | 315.9 M | 319.5 M | 372.3 M | 321.7 M | 427.3 M | 423.1 M | 628.1 M | 499.7 M | 506.3 M | 151 M | 255.8 M | 278.2 M |
| BLCO | 416 M | 416 M | 416 M | 416 M | 416 M | 416 M | 416 M | 416 M | 416 M | 396 M | 260 M | 329 M | 207 M | 130 M | 162 M | 159 M | 205.9 M |
Sotera Health and related stocks such as Protagonist Therapeutics, Oscar Health, and Arcellx Operating Income description
Operating Income is the amount of profit realized from Sotera Health operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Sotera Health Co is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Sotera Health Co | SHC |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 9100 South Hills |
| Exchange | NASDAQ Exchange |
USD 15.79
Check out Sotera Health Performance and Sotera Health Correlation. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Sotera Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.